載入...
Negative allosteric modulators of the human calcium‐sensing receptor bind to overlapping and distinct sites within the 7‐transmembrane domain
BACKGROUND AND PURPOSE: Negative allosteric modulators (NAMs) that target the calcium‐sensing receptor (CaS receptor) were originally developed for the treatment of osteoporosis by stimulating the release of endogenous parathyroid hormone, but failed in human clinical trials. Several chemically and...
Na minha lista:
| 發表在: | Br J Pharmacol |
|---|---|
| Main Authors: | , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7070164/ https://ncbi.nlm.nih.gov/pubmed/31881094 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14961 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|